Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · IEX Real-Time Price · USD
1.660
+0.160 (10.67%)
At close: Mar 28, 2024, 4:00 PM
1.610
-0.050 (-3.01%)
After-hours: Mar 28, 2024, 7:16 PM EDT

Aptose Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2000
Net Income
-51.21-41.82-65.35-55.24-26.28-28.87-11.64-14.24-11.71-7.79
Upgrade
Depreciation & Amortization
0.470.530.620.610.610.090.080.120.080.02
Upgrade
Share-Based Compensation
3.655.2112.9521.442.34.280.821.712.51.35
Upgrade
Other Operating Activities
2.53.778.48-0.711.811.30.520.03-0.760.13
Upgrade
Operating Cash Flow
-44.59-32.32-43.3-33.89-21.56-23.21-10.22-12.39-9.89-6.3
Upgrade
Capital Expenditures
-0.03-0.02-0.21-0.08-0.1-0.33-0.01-0-0.26-0.02
Upgrade
Change in Investments
9.9930.09-3512.71-17.270.34-0.86.46.21-8.14
Upgrade
Other Investing Activities
-------0.080.230.06
Upgrade
Investing Cash Flow
9.9630.07-35.2112.63-17.370.01-0.816.486.17-8.1
Upgrade
Share Issuance / Repurchase
6.910.120.2358.98103.8927.8914.035.730.8127.9
Upgrade
Debt Issued / Paid
00000000-0.020.32
Upgrade
Other Financing Activities
----0.17-0.44-0.02-0.31---
Upgrade
Financing Cash Flow
6.910.120.2358.81103.4527.8713.725.730.7928.22
Upgrade
Exchange Rate Effect
0-00.010.010.02-0.010.01-0.18-1.140
Upgrade
Net Cash Flow
-27.72-2.14-78.2837.5564.544.672.69-0.37-4.0713.82
Upgrade
Free Cash Flow
-44.62-32.35-43.52-33.97-21.66-23.54-10.24-12.39-10.15-6.32
Upgrade
Free Cash Flow Per Share
-6.61-5.26-7.33-6.23-6.48-10.57-6.88-14.59-12.79-18.17
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).